InvestorsHub Logo
Followers 375
Posts 16977
Boards Moderated 4
Alias Born 03/07/2014

Re: None

Sunday, 05/10/2015 10:32:07 AM

Sunday, May 10, 2015 10:32:07 AM

Post# of 92948
LOL BS quote, "RPE Therapy Works! This FACT Trumps Everything Else"

NOTHING'S been proven to "work" yet? A tiny, micro sized, self run phase I proves NOTHING. ZIP. ZERO. NAUGHTA.

It's a blip, a sample so small as to "prove" nothing yet- especially for long term use in human subjects.

http://www.nature.com/news/stem-cells-pass-safety-test-in-vision-loss-trial-1.17451

Lanza says "CAUTION" in highly respected journal "NATURE". Peer review commentary in same article says sample size TOO SMALL to yet be meaningful- doesn't sound like any "slam-dunk" ole "done deal" yet to me?????? Lanza does NOT say anything's been "PROVEN"??? He says MORE TESTING NEEDED to "know" anything for sure?

The VERBATIM article, again, from the highly respected science journal, "NATURE"-

"A company that has spent more than 20 years trying to develop treatments based on embryonic stem cells is taking encouragement from small, preliminary tests of the cells in people with progressive vision loss. If the technique continues to impress in larger trials designed to assess its effectiveness, it could become the first therapy derived from embryonic stem cells to reach the market.

A study of four patients, published in Stem Cell Reports on 30 April1, shows that injection of retinal cells derived from stem cells is safe for people with macular degeneration. The report follows similar results from a trial in 18 patients that was published last October2.

Both studies were meant to assess safety only, and neither included a control group. In the latest study, conducted by researchers in Korea and the United States, three participants were able to read 9–19 more letters further on an eye chart a year after treatment — but two of the three also gained some ground in their untreated eyes."

MORE...

"“This bodes well,” says Robert Lanza, chief scientific officer at Ocata Therapeutics in Marlborough, Massachusetts, and an author of the study. “But I think we need to interpret this improvement cautiously until more controlled studies are done.

The sample size is too small to warrant much excitement, cautions ophthalmologist Tien Yin Wong of the Singapore National Eye Centre. “At this stage it’s hard to say if the visual improvement will be sustained,” he says. “But it’s very promising.”

Lanza speaking to a local MA newspaper-

http://www.telegram.com/article/20141014/NEWS/310149525&Template=printart

"We treated the last UK patients last month, and they also have not seen any safety issues related to the transplanted tissues themselves, either," Dr. Lanza said.

Advanced Cell now hopes to launch a 100-patient, phase 2 study in Stargardt's patients by the end of the year, according to Dr. Lanza.

A second, smaller phase 2 study in patients with age-related macular degeneration would follow, he said. Any treatment might not be ready for FDA approval until 2020, Dr. Lanza said."


That was dated Oct 14, 2014 and the END OF YEAR phase II DID NOT HAPPEN.

In his latest "talk", Lanza now said they "We're hoping in the coming months to certainly initiate our Phase II clinical trial." Oh, so now it's "hoping" and "in the coming MONTHS"??? How many MONTHS plural? 2, 4, 6, 8 months? End of 2015? Who knows what that vague a statement even means IMO? It's MAY 2015 now, but it was supposedly going to "start end of year" in 2014? Now it's we "hope in the coming months"??

NOTHING HAS BEEN "PROVEN" to "work"???? Where and when? Where did that happen?

Some vague "report" of ONE PATIENT- supposedly "seeing" or whatever, that is known in actual, real "science" as an ANECDOTE. It "proves" NOTHING.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.